HUHS1015

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2015
0120132015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND The newly-synthesized naftopidil analog HUHS1015 suppresses tumor growth and induces apoptosis of cells from a variety… (More)
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
The newly synthesized naftopidil analogue HUHS1015 reduced viability of MKN28 and MKN45 human gastric cancer cells in a… (More)
Is this relevant?
2014
2014
The newly synthesized naftopidil analogue HUHS1015 reduced cell viability in malignant pleural mesothelioma cell lines MSTO-211H… (More)
Is this relevant?
2014
2014
Naftopidil is clinically for treatment of benign prostate hyperplasia, and emerging evidence has pointed to its anticancer effect… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2014
2014
We have originally synthesized the naftopidil analogue 1-[2-(2-methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
The aim of the present study was to assess the anticancer effect of several naftopidil analogues on human malignant mesothelioma… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?